The most common reactions include transient digestive upset (nausea, vomiting, stomach cramps, or diarrhea), a mild fishy body odor, headache, or soreness and redness where the injection is given
Pharmacokinetic (PK) objectives vary: some protocols test short-acting pulses that mirror meal-time signaling, while others emphasize sustained exposure to probe AUC-dependent effects
There was no difference in rate of hypoglycemia between DPP-4 inhibition and placebo in four of the studies (9093) whereas one study showed an increased rate of hypoglycemia with the combination (81)
However, in a head-to-head comparison, Tirzepatide led to better weight loss compared to Semaglutide
Additionally, it assists in the formation of antibodies designed to counteract harmful pathogens